Sinus Lift Procedure of the Maxilla in Patients
with Inadequate Bone for Dental Implants
National Taiwan University Hospital Dr. Chen-Ying Wang 2010, Dec 8th Outlines
Maxillary atrophy: classification and surgical protocols
Anatomy of the maxillary sinus In average: - 2.5 cm in width, 3.75 cm in height, 3.0 cm in anterior-posterior depth - pyramidal shape - Mean: 15 cm3 • Sinus pneumatization increases size: - Advancing age - Tooth loss • Ostium located at cranial side, 25-35 mm above the antral floor provides drainage into the nasal cavity impossible for mechanical blockage during sinus lift procedure • Schneiderian membrane: - 0.13-0.5 mm thick •
- Tseng et al., J Taiwan Periodontol(2010) examined 226 sinuses through reformatted
- 47.8% of sinus floors at least one septum, 39% in male, 55% in female - locaton of the septa: anterior region-20.8%, middle region-14.6%, posterior region-27% - Sinus pathology: prevalence 15%, in total edentulous patient 6.6%, in partially edentulous patient 18.2% - The prevalence of sinus septa and pathology are not significant in both male and
The main blood supply to the maxillary sinus: - Posterior superior alveolar artery(PSAA) (Intraossoeus anastomosis with IAr at 18.9 to 19.6mm away from sinus base)(Solar 1999, Elian 2005)
- Posterior lateral nasal artery The main innervation to the maxil ary sinus:
- Superior alveolar branch of maxil ary nerve
- Anterior superior alveolar branch of infraorbital nerve Indication/ contraindication
Indication:
- Native bone height less than 8mm(Jenson OT,1998)
- sinus pathology - former sequelae sinus surgery(Caldwell Luc op)
Maxillary atrophy: classification and surgical protocols
Posterior bone atrophy Type A: Hyperpneumatization – Sinus lift with surgery Type B: Horizontal deficiency – Sinus lift with bone graft Type C: Vertical deficiency – Vertical onlay bone graft +/- sinus lift Type D: Combined deficiency – Vertical and transverse onlay bone graft +/- sinus lift, vestibular plastic surgery Surgical Techniques
- Boyne, 1980: first publication - Tatum, 1986: Top-hinge-trap-door technique
- Summer, 1994: Trans-alveolar technique~ by osteotomes •
Simultaneous or in second phase implant surgery - Less than 5mm native bone height is available, should for two stage procedure ( Misch 1992, Ulm 1995, Lazzara 1996) Bone graft material
- Particulate bone grafts have higher success rates than block grafts ( Jensen
- Histological data: NTUH data - Graft healing time: Most suggested~ 6months(Misch 1993), Demineralized graft~
9 to 12 months(Wheeler 1996, Chanavaz 1990), Mainly autograft~ 3 to 4 months(Jensen OT 1998)
Alternative materials for maxillary sinus augmentation?
BMPs (Cochran, 1997): ideal carrier material for BMPs~
Medication before and after sinus surgery
- prophylactic: amoxicil in, 7 days (Chanavaz,1990 / Misch,1992) - Augmentin: 8~10days
Complications: Diagnosis and management
Systemic disease and medications related Uncontrolled diabetes Osteoporosis with Bisphosphonate medication Immunocompromised patients (AIDS, cyclic neutropenia) Cigarette smoking(-/+) Anatomy and surgical procedure related Perforation of Schneiderian membrane (Raghoebar, 1997):
most common, occurrence 16%~58% Irregularities, sinus septa, root configuration Bleeding Implants into sinus Obliteration of sinus cavity Sinus pathology related Pseudocysts, retention cysts, mucoceles (Gardner,1984)
Infection related Infection: Swelling/pus/purulent/hematoma Wound dehiscence Bone sequestrum Post-operative sinusitis (nasal congestion, purulent discharge, headaches): 10% Oroantral fistula: in very few cases Long-term results
- Overall implant success: 83%~100% - Rough surface is better than smooth surface - Delay implant surgery is better than simultaneously approach - Implant failure rates were relatively high in cases with pre-surgical bone height of
Future development
Conclusion
Sinus bone grafting for gaining bone mass in the atrophic edentulous maxilla has been demonstrated to be both safe and predictable.
CT image is important for sinus surgery pre-op evaluation, diagnosis, treatment planning.
To know the complication during sinus lifting procedure, and always respect the anatomic limitation.
New technology, new adventure and better success rate.
Alendronate Approx. 750 mill. € Trihydrate sodium salt Anticipation Further details on the patent 4) Time of expiry of basic patent: Family of the GB 2118042, SPC would expire on 5) Opposition filed: formally still valid, the patent is not enforceable due to 6) National Nullity action filed: GB 2 118 042 revoked on 10.02.2003 (product and composition claims), Israel (t
Veterinary Parasitology 101 (2001) 405–414Molecular approaches to studying benzimidazoleJ.F. Humbert a , ∗, J. Cabaret b, L. Elard c, V. Leignel d, A. Silvestre ba INRA, Station d’Hydrobiologie Lacustre, BP 511, 74203 Thonon Cedex, France b INRA, Station de Pathologie Aviaire et de Parasitologie, 37380 Nouzilly, France c Laboratoire de Parasitologie Fondamentale et Fonctionnelle,